Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bemiparin for Thrombosis Prevention in Cirrhotic Patients
NCT02802605Phase 3Unknown
- Sponsor
- IDIVAL
- Start
- May 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of bemiparin in deep vein thrombosis (DVT) and portal vein thrombosis (PVT) (2 arms), sponsored by IDIVAL. Primary endpoint: Number of patients with bleeding and liver toxicity at 90 days. Status: unknown.
02
Drugs
bemiparin
03
Conditions
deep vein thrombosis (DVT)portal vein thrombosis (PVT)
Beyond the preview
Go deeper on NCT02802605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02802605.